Kim P. Kamdar Insider Trading
Get free email notifications about insider trading for Kim P. Kamdar.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kim P. Kamdar. Kim P. Kamdar is a 10% Owner in CADENCE PHARMACEUTICALS INC ($CADX) and a Director in Syndax Pharmaceuticals Inc ($SNDX) and a in OBALON THERAPEUTICS INC ($OBLN) and a Director in OBALON THERAPEUTICS INC ($OBLN) and a Director in Neothetics, Inc. ($NEOT).
Address: C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE PRINCETON 08542 NJ
Companies in which Kim P. Kamdar is an Insider
CADENCE PHARMACEUTICALS INC
Trading Symbol: CADXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kim P. Kamdar: 10% Owner
Holdings: 0 shares
Latest Transaction: Mar 21 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Evofem Biosciences, Inc.
Trading Symbol: NEOTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kim P. Kamdar: Director
Holdings: 9,287 shares
Current Value: $15,788
Latest Transaction: Jun 16 2020
$NEOT Market Capitalization: $26.27M
$NEOT Previous Close: $1.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ReShape Lifesciences Inc.
Trading Symbol: OBLNIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Kim P. Kamdar:
Holdings: 27,148 shares
Current Value: $259,535
Latest Transaction: Sep 18 2020
$OBLN Market Capitalization: $158.66M
$OBLN Previous Close: $9.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syndax Pharmaceuticals Inc
Trading Symbol: SNDXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kim P. Kamdar: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 02 2016
$SNDX Market Capitalization: $163.37M
$SNDX Previous Close: $8.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Kim P. Kamdar
Sentiment: All, CADX, NEOT, OBLN, SNDX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 18 2020 | OBLN | OBALON THERAPEUTIC ... | Kamdar Kim P. | Option Exercise | A | 0.77 | 27,250 | 20,983 | 27,250 | ||
Sep 18 2020 | OBLN | OBALON THERAPEUTIC ... | Kamdar Kim P. | Option Exercise | A | 0.00 | 27,250 | 0 | 27,250 | ||
Sep 18 2020 | OBLN | OBALON THERAPEUTIC ... | Kamdar Kim P. | Option Exercise | A | 0.77 | 27,250 | 20,983 | 27,250 | ||
Sep 18 2020 | OBLN | OBALON THERAPEUTIC ... | Kamdar Kim P. | Option Exercise | A | 0.00 | 27,250 | 0 | 27,250 | ||
Jun 16 2020 | NEOT | Evofem Biosciences ... | Kamdar Kim P. | Director | Buy | P | 2.94 | 5,000 | 14,700 | 9,287 | 4.3 K to 9.3 K (+116.63 %) |
May 13 2020 | NEOT | Evofem Biosciences ... | Kamdar Kim P. | Director | Option Exercise | A | 5.06 | 50,000 | 253,000 | 50,000 | |
Aug 08 2019 | OBLN | OBALON THERAPEUTIC ... | Kamdar Kim P. | Director | Option Exercise | P | 4.40 | 9,375 | 41,250 | 9,375 |